TEP1, encoded by a candidate tumor suppressor locus, is a novel protein tyrosine phosphatase regulated by transforming growth factor beta - PubMed (original) (raw)
. 1997 Jun 1;57(11):2124-9.
Affiliations
- PMID: 9187108
TEP1, encoded by a candidate tumor suppressor locus, is a novel protein tyrosine phosphatase regulated by transforming growth factor beta
D M Li et al. Cancer Res. 1997.
Abstract
It has long been postulated that protein tyrosine phosphatases may act as tumor suppressors because of their ability to counteract the oncogenic actions of protein tyrosine kinases. Here we report the cloning and characterization of a novel human protein tyrosine phosphatase, TEP1. TEP1 contains the protein tyrosine phosphatase signature motif, and we show that it possesses an intrinsic protein tyrosine phosphatase activity. TEP1 also shares extensive homology with tensin, a cytoskeletal protein localized to focal adhesions, and with auxilin, a protein involved in synaptic vesicle transport. Immunofluorescence studies show that TEP1 is a cytoplasmic protein. The abundance of TEP1 transcription is altered in many transformed cells. In the transforming growth factor beta-sensitive cells, TEP1 expression is rapidly down-regulated by transforming growth factor beta, a cytokine shown to be involved in regulating cell adhesion and cell motility. We have also mapped the gene encoding TEP1 to chromosome 10q23, a locus that is frequently deleted in a variety of human cancers. TEP1 protein is identical to the protein encoded by the candidate tumor suppressor gene PTEN/MMAC1. Our functional studies of the TEP1 protein suggest that its tumor suppressor function may associate with its intrinsic protein tyrosine phosphatase activity and its cytoplasmic localization.
Similar articles
- Activation of synovial fibroblasts in rheumatoid arthritis: lack of Expression of the tumour suppressor PTEN at sites of invasive growth and destruction.
Pap T, Franz JK, Hummel KM, Jeisy E, Gay R, Gay S. Pap T, et al. Arthritis Res. 2000;2(1):59-64. doi: 10.1186/ar69. Arthritis Res. 2000. PMID: 11219390 Free PMC article. - PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer.
Li J, Yen C, Liaw D, Podsypanina K, Bose S, Wang SI, Puc J, Miliaresis C, Rodgers L, McCombie R, Bigner SH, Giovanella BC, Ittmann M, Tycko B, Hibshoosh H, Wigler MH, Parsons R. Li J, et al. Science. 1997 Mar 28;275(5308):1943-7. doi: 10.1126/science.275.5308.1943. Science. 1997. PMID: 9072974 - Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers.
Steck PA, Pershouse MA, Jasser SA, Yung WK, Lin H, Ligon AH, Langford LA, Baumgard ML, Hattier T, Davis T, Frye C, Hu R, Swedlund B, Teng DH, Tavtigian SV. Steck PA, et al. Nat Genet. 1997 Apr;15(4):356-62. doi: 10.1038/ng0497-356. Nat Genet. 1997. PMID: 9090379 - PTEN/MMAC1/TEP1 in signal transduction and tumorigenesis.
Besson A, Robbins SM, Yong VW. Besson A, et al. Eur J Biochem. 1999 Aug;263(3):605-11. doi: 10.1046/j.1432-1327.1999.00542.x. Eur J Biochem. 1999. PMID: 10469123 Review. - PTEN and myotubularin: novel phosphoinositide phosphatases.
Maehama T, Taylor GS, Dixon JE. Maehama T, et al. Annu Rev Biochem. 2001;70:247-79. doi: 10.1146/annurev.biochem.70.1.247. Annu Rev Biochem. 2001. PMID: 11395408 Review.
Cited by
- Phosphatases: the new brakes for cancer development?
Zhang Q, Claret FX. Zhang Q, et al. Enzyme Res. 2012;2012:659649. doi: 10.1155/2012/659649. Epub 2011 Oct 31. Enzyme Res. 2012. PMID: 22121480 Free PMC article. - Sophocarpine inhibits the progression of glioblastoma via PTEN/PI3K/Akt signaling pathway.
Xing S, Xiong Z, Wang M, Li Y, Shi J, Qian Y, Lei J, Jia J, Zeng W, Huang Z, Jiang Y. Xing S, et al. Am J Cancer Res. 2024 Aug 25;14(8):3757-3772. doi: 10.62347/SQJB1901. eCollection 2024. Am J Cancer Res. 2024. PMID: 39267674 Free PMC article. - A comprehensive analysis of phosphatase and tensin homolog deleted on chromosome 10 (PTEN) loss in colorectal cancer.
Lin PC, Lin JK, Lin HH, Lan YT, Lin CC, Yang SH, Chen WS, Liang WY, Jiang JK, Chang SC. Lin PC, et al. World J Surg Oncol. 2015 May 20;13:186. doi: 10.1186/s12957-015-0601-y. World J Surg Oncol. 2015. PMID: 25986931 Free PMC article. Clinical Trial. - PTEN in propofol-induced insulin resistance in mouse primary hepatocytes.
Zhou L, Wang L, Hu X, Li Y. Zhou L, et al. Exp Ther Med. 2018 Dec;16(6):4831-4835. doi: 10.3892/etm.2018.6815. Epub 2018 Oct 1. Exp Ther Med. 2018. PMID: 30542438 Free PMC article. - Current Position of the Molecular Therapeutic Targets for Ovarian Clear Cell Carcinoma: A Literature Review.
Amano T, Chano T, Yoshino F, Kimura F, Murakami T. Amano T, et al. Healthcare (Basel). 2019 Jul 30;7(3):94. doi: 10.3390/healthcare7030094. Healthcare (Basel). 2019. PMID: 31366141 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Molecular Biology Databases
Research Materials